ASO Visual Abstract: Serum CEA as Prognostic Marker for Overall Survival in Patients with Localized Pancreatic Adenocarcinoma and Nonelevated CA19-9 Levels Treated with FOLFIRINOX as Initial Treatment-A TAPS Consortium Study

TY - JOUR

T1 - ASO Visual Abstract

T2 - Serum CEA as Prognostic Marker for Overall Survival in Patients with Localized Pancreatic Adenocarcinoma and Nonelevated CA19-9 Levels Treated with FOLFIRINOX as Initial Treatment-A TAPS Consortium Study

AU - Trans-Atlantic Pancreatic Surgery (TAPS) Consortium

AU - Doppenberg, Deesje

AU - Stoop, Thomas F.

AU - van Dieren, Susan

AU - Katz, Matthew H.G.

AU - Janssen, Quisette P.

AU - Nasar, Naaz

AU - Prakash, Laura R.

AU - Theijse, Rutger T.

AU - Tzeng, Ching Wei D.

AU - Wei, Alice C.

AU - Zureikat, Amer H.

AU - Groot Koerkamp, Bas

AU - Besselink, Marc G.

PY - 2024/3/1

Y1 - 2024/3/1

UR - http://www.scopus.com/inward/record.url?scp=85184516721&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85184516721&partnerID=8YFLogxK

U2 - 10.1245/s10434-023-14752-1

DO - 10.1245/s10434-023-14752-1

M3 - Article

C2 - 38102327

AN - SCOPUS:85184516721

SN - 1068-9265

VL - 31

SP - 1954

EP - 1955

JO - Annals of surgical oncology

JF - Annals of surgical oncology

IS - 3

ER -